Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7954]

$FDA gives breakthrough therapy designation for ibrutinib for relapsed or refractory mantle cell lymphoma and Waldenstrom's macroglobulinemia$

FDA gives breakthrough therapy designation for ibrutinib for relapsed or refractory mantle cell lymphoma and...

Protein central to cancer stem cell formation provides new potential target

Protein central to cancer stem cell formation provides new potential target

FDA aproves pomalidomide for multiple myeloma where two prior therapies have failed

FDA aproves pomalidomide for multiple myeloma where two prior therapies have failed

Most NCDs could be treated with small number of cheap generic drugs and within existing budgets

Most NCDs could be treated with small number of cheap generic drugs and within existing budgets

Two drugs better one to treat most deadly skin cancer

Two drugs better one to treat most deadly skin cancer

SUVmax provides valuable indicator of progression-free survival in stage I NSCLC patients

SUVmax provides valuable indicator of progression-free survival in stage I NSCLC patients

Hepatic function testing can assist in treatment planning for liver cancer patients

Hepatic function testing can assist in treatment planning for liver cancer patients

Benefits of CT outweigh cancer risks in young adults

Benefits of CT outweigh cancer risks in young adults

Triple-negative breast cancer subtypes identified using microRNA

Triple-negative breast cancer subtypes identified using microRNA

Long-term side-effects of targeted therapies in paediatric cancer patients

Long-term side-effects of targeted therapies in paediatric cancer patients

More from ecancer